Clinical laboratory measurements of the study groups.

Table 2: Clinical laboratory measurements of the study groups.

Clinical Laboratory Measurement

Reference Interval

CTL (n = 12)
Mean ± SD
Median (P25-P75)

HT (n = 14)
Mean ± SD
Median (P25-P75)

STR (n = 13)
Mean ± SD
Median (P25-P75)

P-value^†

HbA1c (%)

< 6.5

5.6 ± 0.4

5.5 (5.4-5.8)

6.0 ± 1.0

5.7 (5.5-63)

6.5 ± 1.1

6.1 (5.9-6.5)

0.01^*

Glucose (mg/dL)

65-99

91.6 ± 11.7

87.5 (84.5-97)

128.1 ± 72.5

109 (103-127)

169.5 ± 67.5

149 (116-180)

< 0.001^*

Calcium (mg/dL)

8.7-10.3

9.6 ± 0.4

9.7 (9.6-9.9)

9.8 ± 0.6

9.9 (9.4-10.0)

9.1 ± 0.5

9.0 (8.8-9.4)

< 0.01^‡^*

Albumin (g/dL)

3.5-5.5

4.4 ± 0.3

4.4 (4.2-4.6)

4.5 ± 0.3

4.4 (4.3-4.6)

4.0 ± 0.4

4.0 (3.7-4.2)

< 0.01^‡^*

CO2 (mmol/L)

18-29

28.7 ± 1.2

28.5 (28-30)

28.3 ± 1.0

28 (28-29)

25.5 ± 2.9

26 (23-27)

< 0.01^*

Chloride (mmol/L)

98-110

99.6 ± 1.8

99 (98-101)

99.5 ± 1.6

99 (99-100)

95.7 ± 25.9

103 (101-104)

0.01^*

CTL: Control Patients; HT: Hypertensive Patients Receiving Treatment; STR: Ischemic Stroke patients.

^†Kruskal-Wallis test was performed to calculate p-values unless otherwise specified; ^‡One-way ANOVA test was performed to calculate p-values; ^*Statistically significant (p < 0.05).